SRARP and breast carcinoma: Therefore, this differential pattern of AR expression can explain a relatively higher expression of C1orf64 observed in ER-positive compared to ER-negative tumors and at the same time a strong correlation between AR and C1orf64 expression across all breast cancer subtypes.